Article Information
History
- January 26, 2022.
Article Versions
- Version 1 (October 22, 2021 - 09:23).
- Version 2 (November 3, 2021 - 10:49).
- Version 3 (November 5, 2021 - 09:01).
- Version 4 (November 6, 2021 - 09:07).
- Version 5 (November 9, 2021 - 10:56).
- You are currently viewing Version 6 of this article (January 26, 2022 - 08:54).
- Version 7 (January 28, 2022 - 11:32).
- View Version 8, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Melina A. Markkanena,#,
- Kaisa Haukkaa,f,
- Katariina M. M. Pärnänena,
- Victorien Tamegnon Dougnonb,
- Isidore Juste O. Bonkoungouc,
- Zakaria Garbad,
- Halidou Tintod,
- Anniina Sarekoskia,
- Antti Karkmana,
- Anu Kantelee,f,* and
- Marko P. J. Virtaa,#,*
- aDepartment of Microbiology, University of Helsinki, Finland
- bResearch Unit in Applied Microbiology and Pharmacology of Natural Substances, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Benin
- cDepartment of Biochemistry and Microbiology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
- dClinical Research Unit Nanoro, Institute for Research in Health Sciences, National Center for Scientific and Technological Research, Burkina Faso
- eMeilahti Infectious Diseases and Vaccine Research Center, MeiVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- fHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- ↵#Corresponding authors: Marko P. J. Virta, marko.virta{at}helsinki.fi, Melina A. Markkanen, melina.markkanen{at}helsinki.fi
↵* Equal contribution